Exploring the interactions of JAK inhibitor and S1P receptor modulator drugs with the human gut microbiome: Implications for colonic drug delivery and inflammatory bowel disease.

Autor: Favaron A; UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, United Kingdom., Abdalla Y; UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, United Kingdom., McCoubrey LE; UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, United Kingdom., Nandiraju LP; UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, United Kingdom., Shorthouse D; UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, United Kingdom., Gaisford S; UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, United Kingdom., Basit AW; UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, United Kingdom. Electronic address: a.basit@ucl.ac.uk., Orlu M; UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, United Kingdom. Electronic address: m.orlu@ucl.ac.uk.

Publikováno v: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2024 Sep 01; Vol. 200, pp. 106845. Date of Electronic Publication: 2024 Jul 05.